The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of survival and local radiotherapy to the bladder versus chemotherapy alone for patients with metastatic urothelial carcinoma (mUC).
 
Benjamin Walker Fischer-Valuck
No Relationships to Disclose
 
Sagar Anil Patel
No Relationships to Disclose
 
Hiram Alberto Gay
No Relationships to Disclose
 
John Paul Christodouleas
Employment - Elekta
 
Paul Sargos
No Relationships to Disclose
 
Yuan Rao
No Relationships to Disclose
 
Ruben Carmona
No Relationships to Disclose
 
Joel Picus
Consulting or Advisory Role - Novo Nordisk; Sanofi
Research Funding - Agensys (Inst); BioClin Therapeutics (Inst); BioClin Therapeutics (Inst); eFFECTOR Therapeutics (Inst); Endocyte (Inst); Innocrin Pharma (Inst); Mirati Therapeutics (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst); TRACON Pharma (Inst)
 
Bruce J. Roth
Research Funding - Medivation (Inst)
 
Eric Kim
No Relationships to Disclose
 
Vivek Arora
No Relationships to Disclose
 
Mohamed S. Zaghloul
No Relationships to Disclose
 
Jeff M. Michalski
Stock and Other Ownership Interests - ViewRay (I)
Consulting or Advisory Role - Blue Earth Diagnostics; Boston Scientific; Merck Sharp & Dohme; Mevion Medical Systems
Research Funding - Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Boston Scientific; Merck Sharp & Dohme
 
Brian Christopher Baumann
No Relationships to Disclose